Member Info for ShareSting

They have more orders to fill.
They will hold it down for as long as they can.

I take it people do realise the only ongoing trial at the moment is the HOME Trial. It’s highly likely this trial will be extended in time and user type.

The Hospital trial results are being reviewed and will be Peer reviewed to add weight to the findings. The COPD data, asthma data and all the safety data will all form
Part of the multi agency applications.

Anything is possible with this company given the unique world we live in today. Emergency use is highly likely iMO.

Take over / Partnership or Licensing deals are all possible this month.

Big money continues to be added. MM’s used the three hostile MotleyFool articles to gather share last week to fill the orders. More large trades are expected tomorrow.

News is imminent!

So we closed with 15 minutes of auction today.
Tomorrow should be interesting. Major buyer is around. Notice the MM’s masked a buy as a sell. These orders have been filled over days so print time / price is irrelevant!

COPD and Peer review is coming. Agency approval will not be far behind IMO.

Significant upside from here.

GLA especially long term holders

News has only been “imminent” from Friday.
That is the first time I have heard the company say that.
They will be waiting for all data. This will be a major Announcement when it lands !

Morning
I believe the home trial will be extended and will include a wider range of patients.
I believe SNG001 will be approved for Hospitals use.
I believe a global licensing or partnership deal will be agreed this month.

People should understand that the trial websites should be ignored for now. The refer to the home study and to be honest the focus should be on agency approval for hospital use.
I really don’t see SNG001 not being approved for emergency use, the data was amazing. The quality of the data was excellent. It will be backed up with COPD data, Asthma Data and 15 years of safety data.

Next week will be exciting!

Morning all

With numbers around our home trial jumping around, I think this confused the market yesterday.

I am still expecting COPD data imminently. Peer review on the hospital trial should also be available any day now.

Then we have the question of agency approval. It is highly likely we will receive some type of approval for SNG001 use in hospitals. The safety data is solid. The performance data is best in world and we have 15 years worth of data in total.

It is easy to forget what Synairgen has achieved in the last 7 months. It is also easy to focus on the negatives, or be distracted by of track debates.

Personally I remain as excited as I was on the 20th July. This company has an outstanding team. They know lung treatment arguably better than anyone in the world.

I hope everyone here can remain focused and positive and ignore the trolls and article from Motley Fool. Just on that, they for all three articles they didn’t verify any of the information printed with Synairgen, they didn’t even ask for an interview!!

Next week will be exciting. GLA

People are looking in the wrong place !

MF are on their 3rd article, desperate for people to sell why?

This share is about to explode with news. In my view positive news.

They have tried to scare investors out just before news.

Won’t say anymore!

Given the news that could land any day, I seriously wouldn’t want to be out of this over the weekend.
Motley Fool tried to damage the reputation of the business with their poorly written article which was full of holes.
A spook this morning on a website which is irrelevant.

At the end of the day I think all long term holders know what is coming and what a positive impact that will have on the website.

GLA and have a wonderful bank holiday

Peer Review
COPD Data... we know this should be good.
Multiple Agency updates.... very exciting
Production update
Multi license deal / partnership/ takeover discussions
And much much more !

I would imagine we have allot of news incoming and we are a news driven business.

Synairgen are in discussions with multiple agencies. That website is not relevant IMO.
We need to hear from the company, they have the best consultants in the world working on this !

I believe some might have jumped to the wrong conclusion this morning !
If anything no news is good news !

CW25 What extended trial.
Do you have a link ?

I have been in this company from day one.
RM knows what he is doing as does the world class team supporting him.
People should look at the bigger picture and not just a website or poorly written article.

I wouldn’t be worried about that.
MHRA could authorise emergency use and also request further data is collated. This could be mega news.

I remember 19th July this chatroom was full of trolls spinning their crap. Same thing is happening now !

I expect RM wants to present a picture.
Peer review confirms Hospital results.
COPD data confirms Safety and effectiveness.
Multi agency application submitted.
Drug Manufacturing update.
Partnership/ takeover discussions update.

Now if he lands that we will be looking at multiples of here.

“1 day” closer !!

Well the last time this board got infected with trolls the share price rocketed. So that’s a good sign.

The joy of being invested here is we can pump a little bit of SNG001 factual data out and it should clear the virus on this board in no time !

TR1’s due and then Peer review and COPD.

GLA.

Hi Miggy
They also will have grants coming into the business as well.
Do you know what is happening with the Dragon trials ?